Plasticell company
Plasticell is a privately held biotechnology company using novel cell culture and drug discovery platforms to produce regenerative small molecule drugs.
Plasticell aims to develop drugs by elucidating the biochemical mechanisms that control the proliferation and differentiation of stem cells, the master cells responsible for tissue development and repair.
Founded Date:
6-24
Last Funding Type:
Venture - Series Unknown
Headquarters:
London, England, United Kingdom
Investors Number:
1
Technology:
Regenerative Medicine
Employee Number:
11-50
Industry:
Regenerative Medicine
Estimated Revenue:
$1M to $10M
Number Of Exists:
Venture - Series Unknown
Funding Status:
N/A
Investor Type:
Company
Investment Stage:
N/A
Total Funding:
£4.2M